EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma

Doron Yablecovitch iD, Moshe Nadler, Shomron Ben-Horin, Orit Picard, Miri Yavzori, Ella Fudim, Moran Tardio Duchan, Emad Sakhnini, Alon Lang, Maor Lahav, Talia Saker, Sandra Neuman und 7 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Doron Yablecovitch und 18 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 7, Syndecan-1, Carcinoma, Pancreatic Ductal, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims and Background Matrix metalloproteinase‐7 (MMP‐7) and Syndecan‐1 (SDC1) are involved in multiple functions during tumorigenesis. We aimed to evaluate the diagnostic and prognostic performance of these serum proteins, as potential biomarkers, in patients with pancreatic ductal adenocarcinoma (PDAC) and benign pancreatic cysts.

Methods

In this case–control study, patients with newly diagnosed PDAC ( N = 121) were compared with the benign cyst ( N = 66) and healthy control ( N = 48) groups. Serum MMP‐7 and SDC1 were measured by ELISA. The diagnostic accuracy of their levels for diagnosing PDAC and pancreatic cysts was computed, and their association with survival outcomes was evaluated.

Results

MMP‐7 median serum levels were significantly elevated in the PDAC (7.3 ng/mL) and cyst groups (3.7 ng/mL) compared with controls (2.9 ng/mL) ( p < 0.001 and 0.02, respectively), and also between the PDAC and cyst groups ( p < 0.001), while SDC1 median serum levels were significantly elevated in PDAC (43.3 ng/mL) compared with either cysts (30.1 ng/mL, p < 0.001) or controls (31.2 ng/mL, p < 0.001). The receiver operating characteristic curve analysis area under the curve in PDAC versus controls was 0.90 and 0.78 for MMP‐7 and SDC1, respectively, while it was 1.0 for the combination of the two and CA 19‐9 ( p < 0.001). The combination of the three biomarkers had a perfect sensitivity (100%).

Conclusions

Due to its high sensitivity, this biomarker panel has the potential to rule out PDAC in suspected cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 7Syndecan-1Carcinoma, Pancreatic DuctalBiomarkers, TumorCA-19-9 AntigenPancreatic NeoplasmsHumansMaleFemaleMiddle AgedAgedCase-Control StudiesPrognosisROC CurveAdultAged, 80 and overPancreatic Cyst

Stichwörter der Autor:innen

Syndecan‐1biomarkersmatrix metalloproteinase‐7pancreatic cancer

Substanzen

Matrix Metalloproteinase 7Syndecan-1Biomarkers, TumorCA-19-9 AntigenMMP7 protein, humanSDC1 protein, human

Autor:innen und Institutionen

  • Gastroenterology Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shalvata Mental Health Center, Hod Hasharon, Israel.
  • Department of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

ORCID-Profile: Doron Yablecovitch, Ido Laish

Zitieren

APA

Yablecovitch, D., Nadler, M., Ben-Horin, S., Picard, O., Yavzori, M., Fudim, E., Duchan, M. T., Sakhnini, E., Lang, A., Lahav, M., Saker, T., Neuman, S., Selinger, L., Freitz, B., Dvir, R., Raitses-Gurevich, M., Golan, T., Levy, I., & Laish, I. (2024). Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70144

Vancouver

Yablecovitch D, Nadler M, Ben-Horin S, Picard O, Yavzori M, Fudim E, et al. Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70144

BibTeX
@article{Yablecovitch2024,
  author = {Yablecovitch, Doron and Nadler, Moshe and Ben-Horin, Shomron and Picard, Orit and Yavzori, Miri and Fudim, Ella and Duchan, Moran Tardio and Sakhnini, Emad and Lang, Alon and Lahav, Maor and Saker, Talia and Neuman, Sandra and Selinger, Limor and Freitz, Biana and Dvir, Revital and Raitses-Gurevich, Maria and Golan, Talia and Levy, Idan and Laish, Ido},
  title = {Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70144}
}
Kostenlos starten →